Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Greenwich LifeSciences Inc shares valued at $51,742 were purchased by Patel Snehal on Dec 18 ’25. At $12.62 per share, Patel Snehal acquired 4,100 shares. The insider’s holdings grew to 5,592,202 shares worth approximately $96.24 million following the completion of this transaction.
Also, Patel Snehal purchased 4,600 shares, netting a total of over 38,502 in proceeds. Following the buying of shares at $8.37 each, the insider now holds 5,588,102 shares.
Before that, Patel Snehal had added 10,600 shares to its account. In a trade valued at $89,358, the CEO and CFO bought Greenwich LifeSciences Inc shares for $8.43 each. Upon closing the transaction, the insider’s holdings increased to 10,600 shares, worth approximately $96.09 million.
As published in their initiating research note from Noble Capital Markets on August 20, 2025, Greenwich LifeSciences Inc [GLSI] has been an Outperform and the price target has been revised to $45. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early September.
Analyzing GLSI Stock Performance
On last trading session, Greenwich LifeSciences Inc [NASDAQ: GLSI] rose 18.12% to $17.21. The stock’s lowest price that day was $14.08, but it reached a high of $17.9599 in the same session. During the last five days, there has been a surge of approximately 60.24%. Over the course of the year, Greenwich LifeSciences Inc shares have jumped approximately 38.90%. Shares of the company reached a 52-week high of $17.99 on 12/24/25 and a 52-week low of $7.78 on 11/24/25.
Support And Resistance Levels for Greenwich LifeSciences Inc (GLSI)
According to the 24-hour chart, there is a support level at 14.86, which, if violated, would cause prices to drop to 12.52. In the upper region, resistance lies at 18.77. The next price resistance is at 20.34. RSI (Relative Strength Index) is 87.22 on the 14-day chart, showing overbought technical sentiment.
Is Greenwich LifeSciences Inc subject to short interest?
Stocks of Greenwich LifeSciences Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.26 million shares to 1.61 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 1.35 million shares. A jump of 16.38% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 20.24 of the overall float, the days-to-cover ratio (short ratio) jumped to 20.24.
